Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3220139
Max Phase: Preclinical
Molecular Formula: C17H15NO4
Molecular Weight: 297.31
Molecule Type: Small molecule
Associated Items:
ID: ALA3220139
Max Phase: Preclinical
Molecular Formula: C17H15NO4
Molecular Weight: 297.31
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)C=C(c2ccccc2[N+](=O)[O-])c2ccc(O)cc2O1
Standard InChI: InChI=1S/C17H15NO4/c1-17(2)10-14(12-5-3-4-6-15(12)18(20)21)13-8-7-11(19)9-16(13)22-17/h3-10,19H,1-2H3
Standard InChI Key: LULOWCCUVXGXJT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 297.31 | Molecular Weight (Monoisotopic): 297.1001 | AlogP: 3.90 | #Rotatable Bonds: 2 |
Polar Surface Area: 72.60 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.36 | CX Basic pKa: | CX LogP: 3.94 | CX LogD: 3.94 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.67 | Np Likeness Score: 0.53 |
1. Oh S, Cho SW, Yang J, Sun HJ, Chung YS, Shin CS, Park SB. (2011) Discovery of a novel benzopyranyl compound as a potent in vitro and in vivo osteogenic agent, 2 (1): [10.1039/C0MD00149J] |
Source(1):